Verrica Pharmaceuticals Statistics
Total Valuation
VRCA has a market cap or net worth of $47.07 million. The enterprise value is $45.98 million.
Important Dates
The last earnings date was Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRCA has 17.18 million shares outstanding. The number of shares has increased by 121.68% in one year.
| Current Share Class | 17.18M |
| Shares Outstanding | 17.18M |
| Shares Change (YoY) | +121.68% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.92% |
| Owned by Institutions (%) | 17.74% |
| Float | 11.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.06 |
| Forward PS | 1.44 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.66
| Current Ratio | 1.66 |
| Quick Ratio | 1.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -62.27% |
| Return on Invested Capital (ROIC) | -193.21% |
| Return on Capital Employed (ROCE) | -224.34% |
| Weighted Average Cost of Capital (WACC) | 12.99% |
| Revenue Per Employee | $301,197 |
| Profits Per Employee | -$569,947 |
| Employee Count | 76 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 9.52 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.84% in the last 52 weeks. The beta is 1.67, so VRCA's price volatility has been higher than the market average.
| Beta (5Y) | 1.67 |
| 52-Week Price Change | -38.84% |
| 50-Day Moving Average | 3.85 |
| 200-Day Moving Average | 5.30 |
| Relative Strength Index (RSI) | 33.99 |
| Average Volume (20 Days) | 60,657 |
Short Selling Information
The latest short interest is 244,405, so 1.42% of the outstanding shares have been sold short.
| Short Interest | 244,405 |
| Short Previous Month | 192,613 |
| Short % of Shares Out | 1.42% |
| Short % of Float | 2.12% |
| Short Ratio (days to cover) | 4.63 |
Income Statement
In the last 12 months, VRCA had revenue of $22.89 million and -$43.32 million in losses. Loss per share was -$2.22.
| Revenue | 22.89M |
| Gross Profit | -1.42M |
| Operating Income | -40.23M |
| Pretax Income | -43.32M |
| Net Income | -43.32M |
| EBITDA | -39.74M |
| EBIT | -40.23M |
| Loss Per Share | -$2.22 |
Full Income Statement Balance Sheet
The company has $14.39 million in cash and $13.30 million in debt, with a net cash position of $1.09 million or $0.06 per share.
| Cash & Cash Equivalents | 14.39M |
| Total Debt | 13.30M |
| Net Cash | 1.09M |
| Net Cash Per Share | $0.06 |
| Equity (Book Value) | -5.97M |
| Book Value Per Share | -0.35 |
| Working Capital | 14.47M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -13.35M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 498,000 |
| Net Borrowing | -40.23M |
| Free Cash Flow | -13.35M |
| FCF Per Share | -$0.78 |
Full Cash Flow Statement Margins
Gross margin is -6.19%, with operating and profit margins of -175.73% and -189.23%.
| Gross Margin | -6.19% |
| Operating Margin | -175.73% |
| Pretax Margin | -189.23% |
| Profit Margin | -189.23% |
| EBITDA Margin | -173.61% |
| EBIT Margin | -175.73% |
| FCF Margin | n/a |
Dividends & Yields
VRCA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -121.68% |
| Shareholder Yield | -121.68% |
| Earnings Yield | -81.01% |
| FCF Yield | -28.36% |
Analyst Forecast
The average price target for VRCA is $13.67, which is 398.91% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.67 |
| Price Target Difference | 398.91% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 6.58% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on July 25, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 25, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
VRCA has an Altman Z-Score of -13.76 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.76 |
| Piotroski F-Score | 3 |